Ustekinumab Medication Information

Learn everything you need to know about Ustekinumab-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

Get up-to-date information on side effects, precautions, warnings, and proper storage to ensure safe usage.

Explore Ustekinumab brand names commonly used in India and internationally, along with detailed pricing information. Consult your healthcare provider for tailored medical advice.

Generic Name : Ustekinumab

Pronunciation : US-te-KIN-ue-mab

ICD Code : Y43.4 Therapeutic Classification : Monoclonal Antibodies

Brand Names or Trade Names of Ustekinumab

International :

Stelara

Why is Ustekinumab Prescribed? (Indications)

This medication is a monoclonal antibody, prescribed for psoriasis. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.

When should Ustekinumab not be taken? (Contraindications)

Hypersensitivity.

What is the dosage of Ustekinumab?

SC- For patients weighing less than 100kg - The recommended dose is 45 mg initially and 4 weeks later, followed by 45 mg every 12 weeks.
For patients weighing more than 100kg- The recommended dose is 90 mg initially and 4 weeks later, followed by 90 mg every 12 weeks.

How should Ustekinumab be taken?

It comes as a solution for injection to be administered by a healthcare provider under the skin.

What are the warnings and precautions for Ustekinumab?

• Caution should be exercised in patients with history of infection, tuberculosis (TB), cancer, nerve disorder called reversible posterior leukoencephalopathy syndrome (RPLS), poor immunity, flu-like symptoms, received a vaccine, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• TB skin test should be performed before using this medication.

• Avoid contact with people who infections that can be spread to others.

• Avoid live vaccination during the treatment period.

♦ Patient may develop increased risk of infections. If it is so consult with your healthcare provider.

♦ It may increase the risk of malignancy.

What are the side effects of Ustekinumab?

Cold, upper respiratory tract infection, headache, fatigue, diarrhea, back pain, dizziness, throat pain, itching, injection site redness, muscle pain and depression.